Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Dec. 31, 2019

											Accumulated
					Additional						Other
	Common Stock				Paid-in			Retained			Comprehensive
	Shares		Amount		Capital			Earnings			Income(Loss)			Total
Balances at June 30, 2019		37,934	$	379	$	316,797		$	931,934		$	(83,521	)	$	1,165,589
Cumulative effect adjustments due to adoption of new accounting standards and other									(879	)					(879	)
Net earnings									14,398						14,398
Other comprehensive income (loss)												(8,106	)		(8,106	)
Common stock issued for exercise of options		94		1		7,854									7,855
Common stock issued for restricted stock awards		50		0		(0	)		(1,926	)					(1,926	)
Cash dividends									(12,169	)					(12,169	)
Stock-based compensation expense						8,267									8,267
Common stock issued to employee stock purchase plan		6		0		1,096									1,096
Employee stock purchase plan expense						99									99
Balances at September 30, 2019		38,084	$	381	$	334,112		$	931,358		$	(91,627	)	$	1,174,224
Net earnings									119,622						119,622
Other comprehensive income (loss)												13,275			13,275
Common stock issued for exercise of options		195		2		18,293									18,295
Common stock issued for restricted stock awards		4		0		(0	)								0
Cash dividends									(12,197	)					(12,197	)
Stock-based compensation expense						10,017									10,017
Common stock issued to employee stock purchase plan
Employee stock purchase plan						112									112
Balance at December 31, 2019		38,283	$	383	$	362,534		$	1,038,783		$	(78,352	)	$	1,323,348

												Accumulated
							Additional					Other
	Common Stock						Paid-in		Retained			Comprehensive
	Shares			Amount			Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2018		37,608		$	376		$	246,568	$	876,931		$	(44,814	)	$	1,079,061
Cumulative effect adjustments due to adoption of new accounting standards and other										25,276			(24,682	)		594
Net earnings										17,403						17,403
Other comprehensive income (loss)													(1,136	)		(1,136	)
Common stock issued for exercise of options		166			2			15,609								15,611
Common stock issued for restricted stock awards		24			0					(2,405	)					(2,405	)
Cash dividends										(12,066	)					(12,066	)
Stock-based compensation expense								11,327								11,327
Common stock issued to employee stock purchase plan		5			0			842								842
Employee stock purchase plan expense								238								238
Balances at September 30, 2018		37,803		$	378		$	274,584	$	905,139		$	(70,632	)	$	1,109,469
Net earnings										17,556						17,556
Other comprehensive income (loss)													(12,379	)		(12,379	)
Share repurchases		(95	)		(1	)				(15,404	)					(15,404	)
Common stock issued for exercise of options		24						2,408								2,408
Common stock issued for restricted stock awards		3			0											-
Cash dividends										(12,086	)					-
Stock-based compensation expense								6,784								6,784
Common stock issued to employee stock purchase plan		0			0											-
Employee stock purchase plan expense								77								77
Balances at December 31, 2018		37,735		$	377		$	283,854	$	895,205		$	(83,011	)	$	1,096,425

	Gains (Losses) on Derivative Instruments			Foreign Currency Translation Adjustments			Total
Balance as of June 30, 2019	$	(9,537	)	$	(73,983	)	$	(83,521	)
Other comprehensive income (loss), net of tax before reclassifications		275			4,264			4,539
Reclassification of loss on derivatives to interest expense, net of taxes ⁽³⁾		629			-			629
Balance as of December 31, 2019⁽¹⁾⁽³⁾	$	(8,633	)	$	(69,719	)	$	(78,352	)

	Gains (Losses) on Derivative Instruments			Foreign Currency Translation Adjustments			Total
Balance as of June 30, 2018⁽²⁾	$	-		$	(69,496	)	$	(69,496	)
Other comprehensive income (loss), net of tax before reclassifications		(3,915	)		(9,600	)		(13,515	)
Balance as of December 31, 2018 ⁽³⁾	$	(3,915	)	$	(79,096	)	$	(83,011	)